Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2583-2591

  Logan, Ryan W ^a   Zhang, Changqing ^a   Murugan, Sengottuvelan ^a   O'Connell, Stephanie ^a   Levitt, Dale ^a   Rosenwasser, Alan M ^b   Sarkar, Dipak K ^a  

^a The State University of New Jersey   (United States)

^b University of Maine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GAMMA INTERFERON; GRANZYME B; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BMAL1 GENE; CANCER GROWTH; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GENE EXPRESSION; GROWTH INHIBITION; IMMUNE RESPONSE; INNATE IMMUNITY; JET LAG; LIGHT DARK CYCLE; LUNG CANCER; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; NONHUMAN; ONCOGENE; PER2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHIFT WORKER; TUMOR IMMUNITY;

ANIMALS; BLOTTING, WESTERN; CHRONOBIOLOGY DISORDERS; CIRCADIAN CLOCKS; CLOCK PROTEINS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; PHOTOPERIOD; RATS; RATS, INBRED F344; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863269133     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102715     Document Type: Article

References (77)

1. Lahti, T. A., T. Partonen, P. Kyyrönen, T. Kauppinen, and E. Pukkala. 2008. Night-time work predisposes to non-Hodgkin lymphoma. Int. J. Cancer 123: 2148-2151.
2. Davis, S., D. K. Mirick, and R. G. Stevens. 2001. Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst. 93: 1557-1562. (Pubitemid 32998485)
3. Hansen, J. 2001. Light at night, shiftwork, and breast cancer risk. J. Natl. Cancer Inst. 93: 1513-1515. (Pubitemid 32998475)
4. Schernhammer, E. S., F. Laden, F. E. Speizer, W. C. Willett, D. J. Hunter, I. Kawachi, and G. A. Colditz. 2001. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl. Cancer Inst. 93: 1563-1568. (Pubitemid 32998486)
5. Viswanathan, A. N., and E. S. Schernhammer. 2009. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett. 281: 1-7.
6. Conlon, M., N. Lightfoot, and N. Kreiger. 2007. Rotating shift work and risk of prostate cancer. Epidemiology 18: 182-183. (Pubitemid 46005923)
7. Kubo, T., K. Ozasa, K. Mikami, K. Wakai, Y. Fujino, Y. Watanabe, T. Miki, M. Nakao, K. Hayashi, K. Suzuki, et al. 2006. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am. J. Epidemiol. 164: 549-555. (Pubitemid 44412783)
8. Kloog, I., A. Haim, R. G. Stevens, and B. A. Portnov. 2009. Global codistribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol. Int. 26: 108-125.
9. Schernhammer, E. S., F. Laden, F. E. Speizer, W. C. Willett, D. J. Hunter, I. Kawachi, C. S. Fuchs, and G. A. Colditz. 2003. Night-shift work and risk of colorectal cancer in the nurses' health study. J. Natl. Cancer Inst. 95: 825- 828.
10. Mormont, M. C., J. Waterhouse, P. Bleuzen, S. Giacchetti, A. Jami, A. Bogdan, J. Lellouch, J. L. Misset, Y. Touitou, and F. Lévi. 2000. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res. 6: 3038-3045. (Pubitemid 30637726)
11. Sephton, S. E., R. M. Sapolsky, H. C. Kraemer, and D. Spiegel. 2000. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92: 994-1000. (Pubitemid 30469965)
12. Chaput, J. P., M. Brunet, and A. Tremblay. 2006. Relationship between short sleeping hours and childhood overweight/obesity: results from the "Québec en Forme" Project. Int. J. Obes. (Lond.) 30: 1080-1085. (Pubitemid 43980575)
13. Morikawa, Y., H. Nakagawa, K. Miura, Y. Soyama, M. Ishizaki, T. Kido, Y. Naruse, Y. Suwazono, and K. Nogawa. 2005. Shift work and the risk of diabetes mellitus among Japanese male factory workers. Scand. J. Work Environ. Health 31: 179-183. (Pubitemid 40895441)
14. Tüchsen, F., H. Hannerz, and H. Burr. 2006. A 12 year prospective study of circulatory disease among Danish shift workers. Occup. Environ. Med. 63: 451-455. (Pubitemid 43974026)
15. Filipski, E., F. Delaunay, V. M. King, M. W. Wu, B. Claustrat, A. Gréchez-Cassiau, C. Guettier, M. H. Hastings, and L. Francis. 2004. Effects of chronic jet lag on tumor progression in mice. Cancer Res. 64: 7879-7885. (Pubitemid 39446921)
16. Filipski, E., X. M. Li, and F. Lévi. 2006. Disruption of circadian coordination and malignant growth. Cancer Causes Control 17: 509-514.
17. Lee, S., L. A. Donehower, A. J. Herron, D. D. Moore, and L. Fu. 2010. Disrupting circadian homeostasis of sympathetic signaling promotes tumor developmentin mice. PLoS ONE 5: e10995.
18. Pendergast, J. S., M. Yeom, B. A. Reyes, Y. Ohmiya, and S. Yamazaki. 2010. Disconnected circadian and cell cycles in a tumor-driven cell line. Commun. Integr. Biol. 3: 536-539.
19. Yu, E. A., and D. R. Weaver. 2011. Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY) 3: 479-493.
20. Castanon-Cervantes, O., M. Wu, J. C. Ehlen, K. Paul, K. L. Gamble, R. L. Johnson, R. C. Besing, M. Menaker, A. T. Gewirtz, and A. J. Davidson. 2010. Dysregulation of inflammatory responses by chronic circadian disruption.J. Immunol. 185: 5796-5805.
21. Keller, M., J. Mazuch, U. Abraham, G. D. Eom, E. D. Herzog, H. D. Volk, A. Kramer, and B. Maier. 2009. A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. USA 106: 21407-21412.
22. Zamai, L., C. Ponti, P. Mirandola, G. Gobbi, S. Papa, L. Galeotti, L. Cocco, and M. Vitale. 2007. NK cells and cancer. J. Immunol. 178: 4011-4016. (Pubitemid 46492347)
23. Dunn, G. P., L. J. Old, and R. D. Schreiber. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137-148. (Pubitemid 39094044)
24. Smyth, M. J., J. Swann, E. Cretney, N. Zerafa, W. M. Yokoyama, and Y. Hayakawa. 2005. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202: 583-588. (Pubitemid 41248410)
25. Street, S. E., Y. Hayakawa, Y. Zhan, A. M. Lew, D. MacGregor, A. M. Jamieson, A. Diefenbach, H. Yagita, D. I. Godfrey, and M. J. Smyth. 2004. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J. Exp. Med. 199: 879-884. (Pubitemid 38375207)
26. Imai, K., S. Matsuyama, S. Miyake, K. Suga, and K. Nakachi. 2000. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11- year follow-up study of a general population. Lancet 356: 1795-1799.
27. Konjevic, G., S. Radenkovic, T. Srdic, V. Jurisic, Lj. Stamatovic, and M. Milovic. 2011. Association of decreased NK cell activity and IFNg expression with pSTAT dysregulation in breast cancer patients. J. BUON 16: 219-226.
28. Cullen, S. P., M. Brunet, and S. J. Martin. 2010. Granzymes in cancer and immunity. Cell Death Differ. 17: 616-623.
29. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510. (Pubitemid 351560519)
30. Cifone, M. G., S. D'Alò, R. Parroni, D. Millimaggi, L. Biordi, S. Martinotti, and A. Santoni. 1999. Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production. Blood 93: 3876-3884. (Pubitemid 29249836)
31. Lee, S. H., T. Miyagi, and C. A. Biron. 2007. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28: 252-259. (Pubitemid 46810349)
32. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, and R. D. Schreiber. 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111. (Pubitemid 32391043)
33. Street, S. E., E. Cretney, and M. J. Smyth. 2001. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 97: 192-197. (Pubitemid 32061260)
34. Logan, R. W., and D. K. Sarkar. 2012. Circadian nature of immune function. Mol. Cell. Endocrinol. 349: 82-90.
35. Albrecht, U., and H. Oster. 2001. The circadian clock and behavior. Behav. Brain Res. 125: 89-91. (Pubitemid 33000445)
36. Silver, R., J. LeSauter, P. A. Tresco, and M. N. Lehman. 1996. A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 382: 810-813. (Pubitemid 26299564)
37. Logan, R. W., A. Arjona, and D. K. Sarkar. 2011. Role of sympathetic nervous system in the entrainment of circadian natural-killer cell function. Brain Behav. Immun. 25: 101-109.
38. Arjona, A., and D. K. Sarkar. 2006. Evidence supporting a circadian control of natural killer cell function. Brain Behav. Immun. 20: 469-476. (Pubitemid 44177763)
39. Arjona, A., and D. K. Sarkar. 2008. Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells. Neurochem. Res. 33: 708-718. (Pubitemid 351341633)
40. Ben-Eliyahu, S., G. G. Page, R. Yirmiya, and A. N. Taylor. 1996. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat. Med. 2: 457-460. (Pubitemid 126664313)
41. Melamed, R., S. Bar-Yosef, G. Shakhar, K. Shakhar, and S. Ben-Eliyahu. 2003. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth. Analg. 97: 1331-1339. (Pubitemid 37310130)
42. Page, G. G., and S. Ben-Eliyahu. 1999. A role for NK cells in greater susceptibility of young rats to metastatic formation. Dev. Comp. Immunol. 23: 87-96. (Pubitemid 29131640)
43. Sarkar, D. K., C. Zhang, S. Murugan, M. Dokur, N. I. Boyadjieva, M. Ortiguela, K. R. Reuhl, and S. Mojtehedzadeh. 2011. Transplantation of b-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma. Cancer Res. 71: 6514-6523.
44. Boyadjieva, N., M. Dokur, J. P. Advis, G. G. Meadows, and D. K. Sarkar. 2001. Chronic ethanol inhibits NK cell cytolytic activity: role of opioid peptide betaendorphin. J. Immunol. 167: 5645-5652. (Pubitemid 33062754)
45. Arjona, A., and D. K. Sarkar. 2005. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J. Immunol. 174: 7618-7624. (Pubitemid 40806266)
46. Arjona, A., N. Boyadjieva, and D. K. Sarkar. 2004. Circadian rhythms of granzyme B, perforin, IFN-gamma, and NK cell cytolytic activity in the spleen: effects of chronic ethanol. J. Immunol. 172: 2811-2817. (Pubitemid 38263665)
47. Wang, K. S., J. Ritz, and D. A. Frank. 1999. IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells. J. Immunol. 162: 299-304. (Pubitemid 29018933)
48. Bryant, J., R. Day, T. L. Whiteside, and R. B. Herberman. 1992. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods 146: 91-103.
49. Kiessling, S., G. Eichele, and H. Oster. 2010. Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag. J. Clin. Invest. 120: 2600-2609.
50. Hut, R. A., A. Scheper, and S. Daan. 2000. Can the circadian system of a diurnal and a nocturnal rodent entrain to ultraviolet light? J. Comp. Physiol. A Neuroethol. Sens. Neural Behav. Physiol. 186: 707-715.
51. Kenagy, G. J. 1980. Center-of-gravity of circadian activity and its relation to free-running period in two rodent species. J. Interdiscipl. Cycle Res. 11: 1-8.
52. Reppert, S. M. 2000. Cellular and molecular basis of circadian timing in mammals. Semin. Perinatol. 24: 243-246. (Pubitemid 30656072)
53. Gibson, E. M., C. Wang, S. Tjho, N. Khattar, and L. J. Kriegsfeld. 2010. Experimental "jet lag" inhibits adult neurogenesis and produces long-term cognitive deficits in female hamsters. PLoS ONE 5: e15267.
54. Kalsbeek, A., C. X. Yi, C. Cailotto, S. E. la Fleur, E. Fliers, and R. M. Buijs. 2011. Mammalian clock output mechanisms. Essays Biochem. 49: 137-151.
55. Boyadjieva, N. I., M. Ortigüela, A. Arjona, X. Cheng, and D. K. Sarkar. 2009. Beta-endorphin neuronal cell transplant reduces corticotropin releasing hormone hyperresponse to lipopolysaccharide and eliminates natural killer cell functional deficiencies in fetal alcohol exposed rats. Alcohol. Clin. Exp. Res. 33: 931-937.
56. Dokur, M., N. Boyadjieva, and D. K. Sarkar. 2004. Catecholaminergic control of NK cell cytolytic activity regulatory factors in the spleen. J. Neuroimmunol. 151: 148-157. (Pubitemid 38624409)
57. Fu, L., and C. C. Lee. 2003. The circadian clock: pacemaker and tumour suppressor. Nat. Rev. Cancer 3: 350-361. (Pubitemid 37328855)
58. Miyazaki, K., M. Wakabayashi, Y. Hara, and N. Ishida. 2010. Tumor growth suppression in vivo by overexpression of the circadian component, PER2. Genes Cells 15: 351-358.
59. Ramsey, M. R., and L. W. Ellisen. 2011. Circadian function in cancer: regulating the DNA damage response. Proc. Natl. Acad. Sci. USA 108: 10379-10380.
60. Trapani, J. A., and M. J. Smyth. 2002. Functional significance of the perforin/ granzyme cell death pathway. Nat. Rev. Immunol. 2: 735-747. (Pubitemid 37328714)
61. van den Broek, M. F., D. Kägi, R. M. Zinkernagel, and H. Hengartner. 1995. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25: 3514-3516. (Pubitemid 26004963)
62. Wallin, R. P., V. Screpanti, J. Michaëlsson, A. Grandien, and H. G. Ljunggren. 2003. Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur. J. Immunol. 33: 2727-2735. (Pubitemid 37337138)
63. Davidson, A. J., O. Castanon-Cervantes, T. L. Leise, P. C. Molyneux, and M. E. Harrington. 2009. Visualizing jet lag in the mouse suprachiasmatic nucleus and peripheral circadian timing system. Eur. J. Neurosci. 29: 171-180.
64. Yan, L. 2011. Structural and functional changes in the suprachiasmatic nucleus following chronic circadian rhythm perturbation. Neuroscience 183: 99-107.
65. Yamazaki, S., R. Numano, M. Abe, A. Hida, R. Takahashi, M. Ueda, G. D. Block, Y. Sakaki, M. Menaker, and H. Tei. 2000. Resetting central and peripheral circadian oscillators in transgenic rats. Science 288: 682-685. (Pubitemid 30241573)
66. Kalsbeek, A., I. F. Palm, S. E. La Fleur, F. A. Scheer, S. Perreau-Lenz, M. Ruiter, F. Kreier, C. Cailotto, and R. M. Buijs. 2006. SCN outputs and the hypothalamic balance of life. J. Biol. Rhythms 21: 458-469. (Pubitemid 44706827)
67. Hayashi, M., S. Shimba, and M. Tezuka. 2007. Characterization of the molecular clock in mouse peritoneal macrophages. Biol. Pharm. Bull. 30: 621-626. (Pubitemid 46570972)
68. Sica, A., L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice, and H. A. Young. 1997. Interaction of NF-kappaB and NFAT with the interferongamma promoter. J. Biol. Chem. 272: 30412-30420. (Pubitemid 27512251)
69. Zhou, S., R. Ou, L. Huang, and D. Moskophidis. 2002. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection. J. Virol. 76: 829-840. (Pubitemid 34033380)
70. Huang, C., E. Bi, Y. Hu, W. Deng, Z. Tian, C. Dong, Y. Hu, and B. Sun. 2006. A novel NF-kappaB binding site controls human granzyme B gene transcription. J. Immunol. 176: 4173-4181. (Pubitemid 44264397)
71. Krukowski, K., J. Eddy, K. L. Kosik, T. Konley, L. W. Janusek, and H. L. Mathews. 2011. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav. Immun. 25: 239-249.
72. Srinivasan, V., G. J. Maestroni, D. P. Cardinali, A. I. Esquifino, S. R. Perumal, and S. C. Miller. 2005. Melatonin, immune function and aging. Immun. Ageing 2: 17.
73. Arjona, A., and D. K. Sarkar. 2006. The circadian gene mPer2 regulates the daily rhythm of IFN-gamma. J. Interferon Cytokine Res. 26: 645-649. (Pubitemid 44689653)
74. Yang, S., A. Liu, A. Weidenhammer, R. C. Cooksey, D. McClain, M. K. Kim, G. Aguilera, E. D. Abel, and J. H. Chung. 2009. The role of mPer2 clock gene in glucocorticoid and feeding rhythms. Endocrinology 150: 2153-2160.
75. Roseboom, P. H., M. A. Namboodiri, D. B. Zimonjic, N. C. Popescu, I. R. Rodriguez, J. A. Gastel, and D. C. Klein. 1998. Natural melatonin "knockdown" in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Brain Res. Mol. Brain Res. 63: 189-197.
76. Filipski, E., and F. Lévi. 2009. Circadian disruption in experimental cancer processes. Integr. Cancer Ther. 8: 298-302.
77. Innominato, P. F., F. A. Lévi, and G. A. Bjarnason. 2010. Chronotherapy and the molecular clock: Clinical implications in oncology. Adv. Drug Deliv. Rev. 62: 979-1001